These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16125495)

  • 1. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
    Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
    Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel diameter should be taken into account in saphenous stenting.
    Lozano I; Rondan J; Avanzas P
    EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
    [No Abstract]   [Full Text] [Related]  

  • 3. The MGuard stent: current promises and limitations.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):642-3. PubMed ID: 20333654
    [No Abstract]   [Full Text] [Related]  

  • 4. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 5. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postoperative percutaneous coronary angioplasty for stenosed aortocoronary vein bypass].
    Otake H; Tanaka N; Mukai K; Fujii S; Michishita I; Shibazaki Y; Genda A; Iwa T
    Kyobu Geka; 1991 Oct; 44(11):900-5. PubMed ID: 1942680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial versus venous bypass grafts in patients with in-stent restenosis.
    Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
    Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
    Ponnuthurai FA; van Gaal WJ; Channon KM
    J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.
    Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848
    [No Abstract]   [Full Text] [Related]  

  • 12. Long drug-eluting stent implantation for a diffusely diseased right internal mammary artery.
    Niccoli G; Biscione C; Conte M; Crea F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):381-3. PubMed ID: 17443108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
    Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
    Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenting for saphenous vein graft disease: have we solved the problem?
    Chauhan MS; Carrozza JP
    J Invasive Cardiol; 2000 Oct; 12(10):513-5. PubMed ID: 11022210
    [No Abstract]   [Full Text] [Related]  

  • 15. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract]   [Full Text] [Related]  

  • 16. Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    D'andrea C; Esposito G; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):875-8. PubMed ID: 19644385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

  • 18. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective Wiktor GX stenting for symptomatic stenosis in old aortocoronary saphenous vein bypass grafts: the Antwerp experience.
    Van Langenhove G; Vermeersch P; Kay IP; Vaerenberg M; Heuten H; Stockman D; Convens C; Albertal M; Vrints C; Van den Branden F; Van den Heuvel P
    J Invasive Cardiol; 1999 May; 11(5):274-80. PubMed ID: 10745530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.